Those who are diagnosed with cancer face a hard decision: Treatment or not? People respond to treatment differently. Doctors have backlogs of data that show how different patients responded to different treatments, but they are unanalyzed, and analyzing them would take years. Enter Reverse The Odds, a mobile game that shows players slides from a cancer patient and asks the player something like “was there blue on the slide?” The slides are pictures of proteins—biomarkers that are key to showing how a patient responded to certain treatments. If lets say the biomarker is blue, and the patient responded well to treatment, then researchers might be able to draw the conclusion that patients with similar biomarkers should opt for treatment. The task is easy but requires a human’s eye and intellect, a computer cannot analyze the raw data. Reverse The Odds is rudimentary, but that’s the point—to breakdown these massive data sets into pieces that anyone can understand, and help analyze. Hopefully making one of life’s hardest decisions easier.
Help cancer patients by playing a mobile game
More of Today's Solutions
Europe’s low-carbon future: Denmark’s North Sea oil field is now a carb...
Once a symbol of fossil fuel extraction, the remote Nini oil field in the North Sea is preparing for a new role: storing millions ...
Read MoreGrace Richardson makes history as first openly gay Miss England: ‘I’ve achiev...
BY THE OPTIMIST DAILY EDITORIAL TEAM When Grace Richardson took the stage at the Miss England final in Wolverhampton, she wasn’t just chasing a ...
Read MoreWorld’s first hydrogen-powered cargo vessel to set sail in Paris this year
In a world's first, a commercial hydrogen-powered cargo vessel will make its maiden voyage later this year. Developed by French shipowner Compagnie Fluvial Transport ...
Read MoreA guide to self-kindness: transforming negative self-talk into positive affir...
As we go through the motions of daily life, it's tempting to listen to our inner critic's constant commentary. Negative self-talk, or the constant ...
Read More
